Business Standard

India to join hands with WHO for developing coronavirus drugs: Govt

At a press briefing on coronavirus at 4 pm, Health Ministry Joint Secretary Lav Agarwal said 75 new cases of coronavirus and four deaths have been reported in the last 24 hours.

A view of Ghazipur vegetable market bustling with activity during a nationwide lockdown in the wake of coronavirus pandemic, in New Delhi
Premium

A view of Ghazipur vegetable market bustling with activity during a nationwide lockdown in the wake of coronavirus pandemic, in New Delhi

Press Trust of India
India is soon likely to participate in the WHO's "solidarity trial" for developing potential drugs for COVID-19, officials said on Friday.
At a press briefing on coronavirus at 4 pm, Health Ministry Joint Secretary Lav Agarwal said 75 new cases of coronavirus and four deaths have been reported in the last 24 hours.
"We are soon likely to participate in the WHO solidarity trial for developing potential drugs for COVID-19. Earlier we did not do it because our numbers were small and our contribution would have looked minuscule," Raman R Gangakhedkar, Head of Epidemiology and Communicable diseases at ICMR, said.
Agarwal said that

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in